絞り込み

17057

広告

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

著者 Chawla S , Blay JY , Rutkowski P , Le Cesne A , Reichardt P , Gelderblom H , Grimer RJ , Choy E , Skubitz K , Seeger L , Schuetze SM , Henshaw R , Dai T , Jandial D , Palmerini E
Lancet Oncol.2019 Nov 05 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (21view , 0users)

Full Text Sources

Medical

Giant-cell tumour of bone (GCTB) is a rare, locally aggressive osteoclastogenic stromal tumour of the bone. This phase 2 study aimed to assess the safety and activity of denosumab in patients with surgically salvageable or unsalvageable GCTB.
PMID: 31704134 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード